However, transplanted CD34+CD38− HSCs frequently gave rise to CD19+ B cells with typical CLL-like phenotype, characterized by aberrant CD5 expression and mono- or oligoclonal IGH rearrangement. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.